{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T11:44:24Z","timestamp":1789818264553,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Health and Labor Sciences Research","award":["H25-AIDS-Ippan-008"],"award-info":[{"award-number":["H25-AIDS-Ippan-008"]}]},{"name":"Health and Labor Sciences Research","award":["H24-AIDS-Ippan-003"],"award-info":[{"award-number":["H24-AIDS-Ippan-003"]}]},{"name":"Health and Labor Sciences Research","award":["H23-AIDS-Ippan-002"],"award-info":[{"award-number":["H23-AIDS-Ippan-002"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"crossref","award":["24659212"],"award-info":[{"award-number":["24659212"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology of Japan","doi-asserted-by":"crossref","award":["15K08509"],"award-info":[{"award-number":["15K08509"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bbrc.2015.06.100","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T13:29:47Z","timestamp":1434634187000},"page":"1267-1272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Fumagillin, a potent angiogenesis inhibitor, induces Kaposi sarcoma-associated herpesvirus replication in primary effusion lymphoma cells"],"prefix":"10.1016","volume":"463","author":[{"given":"Takayuki","family":"Kanno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeko","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madori","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohtaro","family":"Mine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harutaka","family":"Katano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2015.06.100_bib1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM200004063421407","article-title":"Kaposi's sarcoma","volume":"342","author":"Antman","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2015.06.100_bib2","first-page":"2847","article-title":"Kaposi's sarcoma-associated herpesvirus","volume":"vol. 2","author":"Ganem","year":"2005"},{"key":"10.1016\/j.bbrc.2015.06.100_bib3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus","volume":"88","author":"Nador","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2015.06.100_bib4","doi-asserted-by":"crossref","first-page":"14862","DOI":"10.1073\/pnas.93.25.14862","article-title":"Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)","volume":"93","author":"Russo","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.06.100_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1006\/viro.2000.0196","article-title":"Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma and multicentric Castleman's disease","volume":"269","author":"Katano","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2015.06.100_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9440(10)65097-3","article-title":"High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma","volume":"155","author":"Katano","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrc.2015.06.100_bib7","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood.V93.12.4034.412k38_4034_4043","article-title":"Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6","volume":"93","author":"Aoki","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2015.06.100_bib8","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/leu.2009.117","article-title":"Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma","volume":"23","author":"Gasperini","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2015.06.100_bib9","doi-asserted-by":"crossref","first-page":"10866","DOI":"10.1073\/pnas.95.18.10866","article-title":"A\u00a0viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus","volume":"95","author":"Sun","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.06.100_bib10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1128\/JVI.05167-11","article-title":"Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors","volume":"86","author":"Veeranna","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2015.06.100_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1099\/vir.0.025494-0","article-title":"X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma","volume":"92","author":"Lai","year":"2011","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.bbrc.2015.06.100_bib12","doi-asserted-by":"crossref","first-page":"11725","DOI":"10.1073\/pnas.0905316106","article-title":"Toll-like receptor signaling controls reactivation of KSHV from latency, Proc","volume":"106","author":"Gregory","year":"2009","journal-title":"Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.06.100_bib13","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1371\/journal.ppat.0030044","article-title":"Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus","volume":"3","author":"Yu","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrc.2015.06.100_bib14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm0396-342","article-title":"Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture","volume":"2","author":"Renne","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2015.06.100_bib15","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1128\/JVI.02541-05","article-title":"Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription","volume":"80","author":"Lu","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.bbrc.2015.06.100_bib16","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1099\/vir.0.80214-0","article-title":"Inhibition of infectious human herpesvirus 8 production by gamma interferon and alpha interferon in BCBL-1 cells","volume":"85","author":"Pozharskaya","year":"2004","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.bbrc.2015.06.100_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/348555a0","article-title":"Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth","volume":"348","author":"Ingber","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2015.06.100_bib18","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1126\/science.282.5392.1324","article-title":"Structure of human methionine aminopeptidase-2 complexed with fumagillin","volume":"282","author":"Liu","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2015.06.100_bib19","doi-asserted-by":"crossref","first-page":"15183","DOI":"10.1073\/pnas.95.26.15183","article-title":"Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2","volume":"95","author":"Griffith","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.06.100_bib20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1440-1827.2009.02393.x","article-title":"Fumagillin inhibits colorectal cancer growth and metastasis in mice: in\u00a0vivo and in\u00a0vitro study of anti-angiogenesis","volume":"59","author":"Hou","year":"2009","journal-title":"Pathol. Int."},{"key":"10.1016\/j.bbrc.2015.06.100_bib21","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-05-0871","article-title":"A\u00a0novel methionine aminopeptidase-2 inhibitor, PPI-2458, inhibits non-Hodgkin's lymphoma cell proliferation in\u00a0vitro and in\u00a0vivo","volume":"12","author":"Cooper","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2015.06.100_bib22","doi-asserted-by":"crossref","first-page":"10768","DOI":"10.1073\/pnas.0404105101","article-title":"A\u00a0methionine aminopeptidase-2 inhibitor, PPI-2458, for the treatment of rheumatoid arthritis","volume":"101","author":"Bernier","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.06.100_bib23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/(SICI)1096-9071(199908)58:4<394::AID-JMV12>3.0.CO;2-H","article-title":"Establishing and characterizing a CD30-positive cell line harboring HHV- 8 from a primary effusion lymphoma","volume":"58","author":"Katano","year":"1999","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.bbrc.2015.06.100_bib24","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1073\/pnas.051004198","article-title":"Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator","volume":"98","author":"Chen","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.06.100_bib25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/500560","article-title":"Quantitative analysis of Kaposi sarcoma-associated herpesvirus (KSHV) in KSHV-associated diseases","volume":"193","author":"Asahi-Ozaki","year":"2006","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.bbrc.2015.06.100_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.virol.2006.04.009","article-title":"Expression of Kaposi's sarcoma-associated herpesvirus-encoded K10\/10.1 protein in tissues and its interaction with poly(A)-binding protein","volume":"352","author":"Kanno","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.bbrc.2015.06.100_bib27","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<346::AID-JMV15>3.0.CO;2-4","article-title":"Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS-associated Kaposi's sarcoma","volume":"59","author":"Katano","year":"1999","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.bbrc.2015.06.100_bib28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/jmv.21962","article-title":"A\u00a0novel real-time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnoses","volume":"83","author":"Katano","year":"2011","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.bbrc.2015.06.100_bib29","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0006-291X(05)80313-4","article-title":"AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor","volume":"183","author":"Weindel","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2015.06.100_bib30","first-page":"601","article-title":"TNP-470 inhibits growth and the production of vascular endothelial growth factor of uterine carcinosarcoma cells in\u00a0vitro","volume":"20","author":"Emoto","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bbrc.2015.06.100_bib31","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1200\/JCO.1998.16.4.1444","article-title":"Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team","volume":"16","author":"Dezube","year":"1998","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.bbrc.2015.06.100_bib32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/bjc.1994.41","article-title":"Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)","volume":"69","author":"Kusaka","year":"1994","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.100_bib33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bcp.2004.05.020","article-title":"Participation of cyclin D1 deregulation in TNP-470-mediated cytostatic effect: involvement of senescence","volume":"68","author":"Lien","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2015.06.100_bib34","series-title":"Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Cambridge","article-title":"Reactivation and lytic replication of EBV","author":"Kenney","year":"2007"},{"key":"10.1016\/j.bbrc.2015.06.100_bib35","doi-asserted-by":"crossref","first-page":"12782","DOI":"10.1073\/pnas.97.23.12782","article-title":"The antiangiogenic agent TNP-470 requires p53 and p21CIP\/WAF for endothelial cell growth arrest","volume":"97","author":"Yeh","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.06.100_bib36","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1371\/journal.ppat.0030044","article-title":"Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus","volume":"3","author":"Yu","year":"2007","journal-title":"PLoS Pathog."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15301522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15301522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T23:11:55Z","timestamp":1655507515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15301522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0006291X15301522"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.100","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fumagillin, a potent angiogenesis inhibitor, induces Kaposi sarcoma-associated herpesvirus replication in primary effusion lymphoma cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}